Review



human monocytic leukemia cell line  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC human monocytic leukemia cell line
    Human Monocytic Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 19995 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocytic leukemia cell line/product/ATCC
    Average 99 stars, based on 19995 article reviews
    human monocytic leukemia cell line - by Bioz Stars, 2026-05
    99/100 stars

    Images



    Similar Products

    99
    ATCC human monocytic leukemia cell line
    Human Monocytic Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocytic leukemia cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human monocytic leukemia cell line - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC monocytic human leukemia thp 1 cell line
    Monocytic Human Leukemia Thp 1 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/monocytic human leukemia thp 1 cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    monocytic human leukemia thp 1 cell line - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human monocytic leukemia cell line thp 1
    Human Monocytic Leukemia Cell Line Thp 1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocytic leukemia cell line thp 1/product/ATCC
    Average 99 stars, based on 1 article reviews
    human monocytic leukemia cell line thp 1 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human acute monocytic leukemia cell line thp1
    Human Acute Monocytic Leukemia Cell Line Thp1, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human acute monocytic leukemia cell line thp1/product/ATCC
    Average 99 stars, based on 1 article reviews
    human acute monocytic leukemia cell line thp1 - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human monocytic leukemia thp 1 cell lines
    βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; <t>right)</t> <t>THP-1</t> cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.
    Human Monocytic Leukemia Thp 1 Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocytic leukemia thp 1 cell lines/product/ATCC
    Average 99 stars, based on 1 article reviews
    human monocytic leukemia thp 1 cell lines - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human monocyte leukemia cell line
    βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; <t>right)</t> <t>THP-1</t> cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.
    Human Monocyte Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocyte leukemia cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human monocyte leukemia cell line - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human monocytic leukemia cell line thp 1 cells
    βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; <t>right)</t> <t>THP-1</t> cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.
    Human Monocytic Leukemia Cell Line Thp 1 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocytic leukemia cell line thp 1 cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    human monocytic leukemia cell line thp 1 cells - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human monocyte leukemia cell line thp
    βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; <t>right)</t> <t>THP-1</t> cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.
    Human Monocyte Leukemia Cell Line Thp, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human monocyte leukemia cell line thp/product/ATCC
    Average 99 stars, based on 1 article reviews
    human monocyte leukemia cell line thp - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    99
    ATCC human acute monocytic leukemia cell line
    βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; <t>right)</t> <t>THP-1</t> cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.
    Human Acute Monocytic Leukemia Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human acute monocytic leukemia cell line/product/ATCC
    Average 99 stars, based on 1 article reviews
    human acute monocytic leukemia cell line - by Bioz Stars, 2026-05
    99/100 stars
      Buy from Supplier

    Image Search Results


    βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; right) THP-1 cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.

    Journal: Blood

    Article Title: NLRP3 inflammasome blockade treats intestinal inflammation associated with chronic granulomatous disease

    doi: 10.1182/blood.2025029676

    Figure Lengend Snippet: βHB inhibits NLRP3 inflammasome activity in human cells in the context of CGD. Western blot analysis of IL-1β (pro–IL-1β and active IL-1β) and β-actin (loading control) expression in WT (left) compared to CYBB −/− (ie, CGD; right) THP-1 cells (A) or PBMCs from a healthy person and a patient with CGD (C) that were either unstimulated, treated with the nigericin trigger (1 hour) alone (nigericin), or stimulated with lipopolysaccharide (LPS; 3 hours) and nigericin (1 hour) with or without NLRP3 inhibition with different doses of βHB (1mM-20mM) 30 minutes before adding the nigericin trigger. The last lane shows cells treated with 10mM βHB alone (ie, no priming and no trigger). The measurement of IL-1β, IL-6, and TNF levels in cell culture supernatants after the treatment of WT and CYBB −/− THP-1 cells (B) or healthy and CGD PBMCs (D) with either PBS (unstimulated), LPS (3 hours) and nigericin (1 hour; stimulated), or LPS followed by NLRP3 inhibition with 20mM βHB before (stimulated + βHB) or 10μM MCC950 (stimulated + MCC950) for 30 minutes before adding nigericin. Data in panels C-D are representative of 2 independent experiments. Significance was determined using multiple Mann-Whitney U tests for panel C or unpaired t tests for panel D, with data represented as median ± IQR or mean ± SEM, respectively. Stim., stimulated; Unstim., unstimulated.

    Article Snippet: In vitro experiments were performed using human monocytic leukemia THP-1 cell lines, including WT THP-1 (TIB-202; American Type Culture Collection) and NOX2-deficient ( CYBB −/− ) THP-1 cells (generously provided by Fabien Touzot, CHU Sainte-Justine ), cultured in RPMI 1640 (Gibco) supplemented with 10% heat-inactivated fetal bovine serum (Gibco) and 1% penicillin-streptomycin-glutamine (Gibco).

    Techniques: Activity Assay, Western Blot, Control, Expressing, Inhibition, Cell Culture, MANN-WHITNEY